Regulatory News
Wednesday, January 4, 2017
BRIEF-Cidara Therapeutics completes enrollment in phase 2 Radiant trial
* Cidara Therapeutics completes enrollment in phase 2
Radiant trial evaluating novel antifungal CD101 topical in
vulvovaginal candidiasis
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment